Biomarin Pharmaceutical Inc posts $596.42 million revenue in quarter ended Mar 31, 2023
By USInMinutes - Apr 29, 2023, 03:57 AM ET
Last Updated - Jul 18, 2023, 03:46 PM EDT
Key fundamental financials
profit of $50.85 million
earnings per share of $0.27
Revenue of $596.42 million
Biomarin Pharmaceutical Inc [BMRN] has reported $50.85 million profit for the fiscal quarter ending Mar 31, 2023 while the earnings for the same period were $0.27 per share.
Revenue for the quarter was $596.42 million with operating income of $59.35 million.
The Novato, California (CA)-based company operating in the pharmaceutical preparations sector has total shareholders equity of $4,659.04 million.
